Metagenomi Common Stock Stock Price Prediction
| MGX Stock | 1.69 0.06 3.43% |
Momentum 51
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.54) | EPS Estimate Current Year (2.34) | EPS Estimate Next Year (1.82) | Wall Street Target Price 9.3333 | EPS Estimate Current Quarter (0.53) |
Using Metagenomi Common hype-based prediction, you can estimate the value of Metagenomi Common Stock from the perspective of Metagenomi Common response to recently generated media hype and the effects of current headlines on its competitors.
Metagenomi Common Stock Hype to Price Pattern
Investor biases related to Metagenomi Common's public news can be used to forecast risks associated with an investment in Metagenomi. The trend in average sentiment can be used to explain how an investor holding Metagenomi can time the market purely based on public headlines and social activities around Metagenomi Common Stock. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Metagenomi Common's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Metagenomi Common.
The fear of missing out, i.e., FOMO, can cause potential investors in Metagenomi Common to buy its stock at a price that has no basis in reality. In that case, they are not buying Metagenomi because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Metagenomi Common after-hype prediction price | USD 1.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Metagenomi | Build AI portfolio with Metagenomi Stock |
Metagenomi Common After-Hype Price Prediction Density Analysis
As far as predicting the price of Metagenomi Common at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Metagenomi Common or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Metagenomi Common, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Metagenomi Common Estimiated After-Hype Price Volatility
In the context of predicting Metagenomi Common's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Metagenomi Common's historical news coverage. Metagenomi Common's after-hype downside and upside margins for the prediction period are 0.08 and 6.13, respectively. We have considered Metagenomi Common's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Metagenomi Common is risky at this time. Analysis and calculation of next after-hype price of Metagenomi Common Stock is based on 3 months time horizon.
Metagenomi Common Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Metagenomi Common is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Metagenomi Common backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Metagenomi Common, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.68 | 4.50 | 0.06 | 0.12 | 8 Events / Month | 7 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
1.69 | 1.63 | 3.55 |
|
Metagenomi Common Hype Timeline
On the 25th of January Metagenomi Common Stock is traded for 1.69. The entity has historical hype elasticity of -0.06, and average elasticity to hype of competition of 0.12. Metagenomi is forecasted to decline in value after the next headline, with the price expected to drop to 1.63. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -3.55%, whereas the daily expected return is now at -0.68%. The volatility of related hype on Metagenomi Common is about 2528.09%, with the expected price after the next announcement by competition of 1.81. About 29.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.37. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Metagenomi Common Stock recorded a loss per share of 2.39. The entity had not issued any dividends in recent years. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out Metagenomi Common Basic Forecasting Models to cross-verify your projections.Metagenomi Common Related Hype Analysis
Having access to credible news sources related to Metagenomi Common's direct competition is more important than ever and may enhance your ability to predict Metagenomi Common's future price movements. Getting to know how Metagenomi Common's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Metagenomi Common may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| DTIL | Precision BioSciences | 0.09 | 5 per month | 0.00 | (0.17) | 5.99 | (8.82) | 28.04 | |
| ATYR | aTyr Pharma | (0.01) | 9 per month | 0.00 | (0.12) | 7.14 | (6.41) | 22.83 | |
| ADVM | Adverum Biotechnologies | 0.00 | 8 per month | 3.70 | 0.07 | 10.34 | (6.79) | 40.97 | |
| ARTV | Artiva Biotherapeutics Common | 0.26 | 8 per month | 7.89 | 0.04 | 10.83 | (11.20) | 118.69 | |
| STRO | Sutro Biopharma | 0.54 | 11 per month | 5.37 | 0.08 | 11.76 | (8.62) | 27.28 | |
| QNCX | Quince Therapeutics | (0.34) | 13 per month | 4.21 | 0.13 | 11.88 | (7.90) | 42.36 | |
| IFRX | InflaRx NV | (0.23) | 8 per month | 0.00 | (0.04) | 10.61 | (9.17) | 43.11 | |
| KLRS | Kalaris Therapeutics | 1.77 | 9 per month | 4.48 | 0.18 | 15.58 | (8.21) | 32.70 | |
| CNTB | Connect Biopharma Holdings | (0.23) | 4 per month | 3.95 | 0.10 | 11.89 | (6.63) | 36.83 | |
| ALXO | Alx Oncology Holdings | (0.07) | 7 per month | 0.00 | (0.02) | 12.82 | (9.41) | 27.69 |
Metagenomi Common Additional Predictive Modules
Most predictive techniques to examine Metagenomi price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Metagenomi using various technical indicators. When you analyze Metagenomi charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Metagenomi Common Predictive Indicators
The successful prediction of Metagenomi Common stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Metagenomi Common Stock, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Metagenomi Common based on analysis of Metagenomi Common hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Metagenomi Common's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Metagenomi Common's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Interest Debt Per Share | 1.29 | 1.22 | 1.41 | 1.34 | Revenue Per Share | 1.19 | 1.4 | 1.26 | 1.32 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Metagenomi Stock Analysis
When running Metagenomi Common's price analysis, check to measure Metagenomi Common's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Metagenomi Common is operating at the current time. Most of Metagenomi Common's value examination focuses on studying past and present price action to predict the probability of Metagenomi Common's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Metagenomi Common's price. Additionally, you may evaluate how the addition of Metagenomi Common to your portfolios can decrease your overall portfolio volatility.